Ponatinib as targeted therapy for FGFR1 fusions associated...

Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome

Chase, A., Bryant, C., Score, J., Cross, N. C. P.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
98
Language:
english
Journal:
Haematologica
DOI:
10.3324/haematol.2012.066407
Date:
January, 2013
File:
PDF, 583 KB
english, 2013
Conversion to is in progress
Conversion to is failed